Normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube or IV hydration) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube… compared with placebo; GRADE not reported.
1 finding from 1 review
Interruptions to cancer treatment (chemotherapy delays/discontinuations) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in interruptions to cancer treatment (chemotherapy… compared with placebo; GRADE not reported.
1 finding from 1 review
Interruptions to cancer treatment (unscheduled radiotherapy breaks of 5 or more days) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in interruptions to cancer treatment (unscheduled radiotherapy breaks… compared with placebo; GRADE not reported.
1 finding from 1 review
Intervention not reported
Change in weight (kg):1 at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in height (cm):1 at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total calories (Kcal/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total protein (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total fat (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Adverse events: · adults and children with cystic fibrosis
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
Intervention not reported
Change in lung function ‐ FEV₁ (% predicted): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Live birth or ongoing pregnancy · ovarian stimulation protocols for women undergoing ART
Progestogen showed no clear difference in live birth or ongoing pregnancy (Prog + Ant vs Ant) compared with placebo or no pretreatment (low certainty).
2 findings from 1 review
Pregnancy loss · ovarian stimulation protocols for women undergoing ART
Progestogen showed no clear difference in pregnancy loss (Prog + Ag vs Ag) compared with placebo or no pretreatment (low certainty).
2 findings from 1 review
Multiple pregnancy rate · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
OHSS · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · ovarian stimulation protocols for women undergoing ART
Oestrogen showed no clear difference in live birth or ongoing pregnancy (Oestr + Ant vs Ant) compared with no pretreatment (moderate certainty).
2 findings from 1 review
Pregnancy loss · ovarian stimulation protocols for women undergoing ART
It is very uncertain whether oestrogen changes pregnancy loss (Oestr + Ant vs Ant) compared with no pretreatment (very low certainty).
2 findings from 1 review
Multiple pregnancy rate · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
OHSS rate (Oestr + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
OHSS · ovarian stimulation protocols for women undergoing ART
It is very uncertain whether oestrogen changes OHSS rate (Oestr + Ant vs Ag) compared with no pretreatment (very low certainty).
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe acute postoperative pain
1 finding from 1 review